Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	11.32	7.11	7.83	8.54	3.19
Cash & Short-Term Investments	11.32	7.11	7.83	8.54	3.19
Cash Growth	59.23%	-9.27%	-8.24%	167.33%	182.11%
Receivables	29.21	19.45	3.09	3.06	3.5
Inventory	16.24	12.93	9.55	6.74	5.01
Prepaid Expenses	0.98	0.52	1.03	0.53	0.49
Total Current Assets	57.74	40.01	21.51	18.86	12.19
Property, Plant & Equipment	14.1	14.61	10.44	6.98	6.86
Other Intangible Assets	0.29	0.29	0.29	0.47	0.47
Long-Term Deferred Tax Assets	18.37	22.16	2.17	2.17	-
Long-Term Deferred Charges	5.35	6.05	6.05	6.17	6.17
Other Long-Term Assets	0.55	0.53	0.43	0.5	0.5
Total Assets	96.39	83.65	40.9	35.15	26.19
Accounts Payable	2.96	2.71	2.45	1.43	0.93
Accrued Expenses	3.45	4.82	4.63	4.28	4.27
Short-Term Debt	4	4	-	-	-
Current Portion of Long-Term Debt	0.25	0.3	0.31	0.35	0.41
Current Portion of Leases	0.84	0.72	0.01	0.2	0.19
Current Income Taxes Payable	0.34	0.49	0.41	0.41	-
Current Unearned Revenue	0.01	0.01	0.01	0.01	0.01
Total Current Liabilities	11.84	13.05	7.83	6.69	5.81
Long-Term Debt	3.03	3.28	3.56	1.39	1.74
Long-Term Leases	2.8	3.44	-	0.84	0.04
Long-Term Unearned Revenue	-	0.01	0.02	0.03	0.05
Other Long-Term Liabilities	25.2	6.3	0.52	0.98	2.4
Total Liabilities	42.87	26.07	11.94	9.93	10.04
Common Stock	1.07	1.07	1.01	1.01	1.01
Additional Paid-In Capital	173.46	173.21	164.75	164.58	164.41
Retained Earnings	-120.7	-116.39	-136.5	-140.06	-148.96
Treasury Stock	-0.31	-0.31	-0.31	-0.31	-0.31
Total Common Equity	53.52	57.58	28.96	25.22	16.15
Shareholders' Equity	53.52	57.58	28.96	25.22	16.15
Total Liabilities & Equity	96.39	83.65	40.9	35.15	26.19
Total Debt	10.91	11.74	3.89	2.78	2.38
Net Cash (Debt)	0.4	-4.63	3.94	5.75	0.81
Net Cash Growth	-	-	-31.44%	606.63%	-
Net Cash Per Share	0.00	-0.00	0.00	0.01	0.00
Filing Date Shares Outstanding	1,068	1,068	1,014	1,011	1,009
Total Common Shares Outstanding	1,068	1,068	1,014	1,011	1,009
Working Capital	45.9	26.96	13.68	12.17	6.38
Book Value Per Share	0.05	0.05	0.03	0.02	0.02
Tangible Book Value	53.23	57.29	28.67	24.76	15.69
Tangible Book Value Per Share	0.05	0.05	0.03	0.02	0.02
Land	11.65	11.06	10.77	5.46	5.46
Machinery	15.71	15.02	14.24	13.85	13.35

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.